Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-10, Stock:LLY, The news for the past five days is as follows:
2021-12-03: NEWS1: Eli Lilly's COVID-19 treatment now authorized high-risk patients 'of any age'.NEWS2: UPDATE 1-FDA clears use of Lilly's COVID-19 antibody therapy for kids.NEWS3: Lilly's COVID-19 antibody treatment authorized for young children and infants.NEWS4: Lilly's bamlanivimab with etesevimab authorized as the first and only neutralizing antibody therapy for emergency use in COVID-19 patients under the age of 12.
2021-12-06: NEWS1: AbbVie (ABBV) Adds FDA-Issued New Warnings to Rinvoq's Label.NEWS2: Lilly (LLY) COVID-19 Antibody Gets FDA Nod for Use in Kids.
2021-12-07: NEWS1: Here is What Hedge Funds Think About Eli Lilly and Company (LLY).NEWS2: 10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors.NEWS3: Biohaven (BHVN) Intranasal Migraine Therapy Meets Goal in Study.NEWS4: Roche (RHHBY) Actemra Gets CHMP Recommendation for COVID-19.
2021-12-08: NEWS1: Eli Lilly's Pipeline Strength Paints a Promising Outlook.NEWS2: UPDATE 2-China approves Brii Biosciences antibody COVID treatment.
2021-12-09: NEWS1: AstraZeneca (AZN) Gets FDA Nod for COVID Prevention Drug.NEWS2: New Lilly Study Reveals Underappreciation of Bowel Urgency as a Symptom of Ulcerative Colitis and Highlights Communication Gap Between Healthcare Providers and Patients.

Answer: Rise